Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Pfizer, Inc.    PFE

PFIZER, INC.

(PFE)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
05/27/2020 05/28/2020 05/29/2020 06/01/2020 06/02/2020 Date
37.41(c) 38.18(c) 38.19(c) 35.46(c) 36.16(c) Last
24 576 965 21 371 034 46 146 287 73 005 888 40 503 656 Volume
-0.21% +2.06% +0.03% -7.15% +1.97% Change
More quotes
Financials (USD)
Sales 2020 46 506 M - -
Net income 2020 11 419 M - -
Net Debt 2020 33 950 M - -
P/E ratio 2020 18,3x
Yield 2020 4,18%
Sales 2021 46 774 M - -
Net income 2021 12 276 M - -
Net Debt 2021 30 417 M - -
P/E ratio 2021 16,8x
Yield 2021 4,34%
Capitalization 201 B 201 B -
EV / Sales 2020 5,05x
EV / Sales 2021 4,94x
Nbr of Employees 88 300
Free-Float 59,1%
More Financials
Company
Pfizer, Inc. the world's leading pharmaceutical group. Net sales break down by family of products as follows: - biopharmaceuticals (76.2%): innovative drugs for the treatment of cancer, inflammatory, autoimmune, infectious, metabolic, cardiovascular and rare diseases, vaccines, etc. In addition, the group develops an active pharmaceutical ingredient manufacturing activity; - generic pharmaceutical products (19.8%;... 
Sector
Pharmaceuticals
Calendar
06/13Presentation
More about the company
Surperformance© ratings of Pfizer, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on PFIZER, INC.
10:12aMAYNE PHARMA : Toni Nesci named head of Mayne Contract Services and New Website ..
AQ
06:09aInvestors Channel Over $150 Billion Into Coronavirus Bonds
DJ
06/02Health Care Up, But Not By Much, Amid Cyclical Bias -- Health Care Roundup
DJ
06/02PFIZER : Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare ..
BU
06/02PFIZER : to Invest $500 Million in Biotech Companies
DJ
06/02PFIZER : Establishes New Program to Support Continued Biotechnology Innovation
BU
06/01Stocks rise on recovery hopes
RE
06/01PFIZER INC : Entry into a Material Definitive Agreement, Financial Statements an..
AQ
06/01Health Care Down After Pfizer, Gilead Setbacks In Drug Trials -- Health Care ..
DJ
06/01WALL STREET STOCK EXCHANGE : Stocks Close Day With Modest Gains
DJ
06/01Coty, Beyond Meat rise; Pfizer, Gilead Sciences fall
AQ
06/01WALL STREET STOCK EXCHANGE : Stocks Close Day With Modest Gains
DJ
06/01WALL STREET STOCK EXCHANGE : Stocks Start Week With Modest Gains
DJ
06/01PFIZER : Shares Down 7%; Breast Cancer Study Unlikely to Show Significant Improv..
DJ
06/01WALL STREET STOCK EXCHANGE : Stocks Start Week With Modest Gains
DJ
More news
News in other languages on PFIZER, INC.
10:12aMAYNE PHARMA : Toni Nesci named head of Mayne Contract Services and New Website ..
06:09aInvestors Channel Over $150 Billion Into Coronavirus Bonds
06/02Health Care Up, But Not By Much, Amid Cyclical Bias -- Health Care Roundup
06/02Aktien New York Schluss: Soziale Unruhen halten die Indizes nicht auf
06/02PFIZER : Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare ..
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 41,28 $
Last Close Price 36,16 $
Spread / Highest target 52,1%
Spread / Average Target 14,2%
Spread / Lowest Target -3,21%
EPS Revisions
Managers
NameTitle
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Business Operations
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
W. Don Cornwell Independent Director
Suzanne Nora Johnson Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER, INC.-7.71%200 863
JOHNSON & JOHNSON1.63%390 579
ROCHE HOLDING AG6.64%296 977
MERCK & CO., INC.-11.12%204 048
NOVARTIS AG-10.13%189 331
ABBVIE INC.2.82%160 444